JGB-1-155

JGB-1-155, is a drug which acts as a selective positive allosteric modulator of the enzyme nicotinamide phosphoribosyltransferase (NAMPT).

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

JGB-1-155, is a drug which acts as a selective positive allosteric modulator of the enzyme nicotinamide phosphoribosyltransferase (NAMPT). It has neuroprotective effects, and was developed as a potential treatment for neurodegenerative diseases such as Alzheimer's disease.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1365803362 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.